<DOC>
	<DOCNO>NCT00108836</DOCNO>
	<brief_summary>This study test efficacy , safety tolerability XBD173 treatment generalize anxiety disorder patient .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability XBD173 Patients With Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Current doctor 's diagnosis generalize anxiety disorder In need psychiatric treatment Willingness complete aspect study Current doctor 's diagnosis major depression History schizophrenia schizoaffective disorder Drug dependence within 2 month prior study start For detailed information eligibility , please contact study center near ( see ) , call 18627788300 , visit follow website : www.novartisclinicaltrials.com</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>GAD</keyword>
	<keyword>Anxiety</keyword>
	<keyword>XBD173</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
</DOC>